UiPath (NYSE:PATH) Given New $10.00 Price Target at UBS Group

UiPath (NYSE:PATH) had its price target reduced by stock analysts at UBS Group from $14.00 to $10.00 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has a “sell” rating on the stock. UBS Group’s target price would suggest a potential downside of 1.04% from the company’s previous close.

PATH has been the topic of a number of other reports. Evercore ISI cut their target price on shares of UiPath from $16.00 to $12.00 and set an “in-line” rating on the stock in a research note on Thursday. Morgan Stanley dropped their target price on UiPath from $16.00 to $12.00 and set an “equal weight” rating on the stock in a report on Thursday. Wells Fargo & Company decreased their target price on UiPath from $13.00 to $11.00 and set an “equal weight” rating for the company in a research note on Thursday. BMO Capital Markets raised their price objective on shares of UiPath from $15.00 to $16.00 and gave the stock a “market perform” rating in a report on Friday, December 6th. Finally, Mizuho cut their price target on shares of UiPath from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Thursday. Two analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $15.22.

UiPath Stock Down 14.6 %

PATH stock traded down $1.73 during midday trading on Thursday, hitting $10.11. The company’s stock had a trading volume of 21,204,739 shares, compared to its average volume of 9,482,741. The firm has a 50-day simple moving average of $13.47 and a 200-day simple moving average of $13.18. The firm has a market capitalization of $5.55 billion, a P/E ratio of -63.22 and a beta of 1.00. UiPath has a 52-week low of $9.37 and a 52-week high of $25.47.

Insider Activity at UiPath

In other news, CFO Ashim Gupta sold 47,227 shares of UiPath stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $13.06, for a total transaction of $616,784.62. Following the completion of the transaction, the chief financial officer now owns 856,538 shares of the company’s stock, valued at $11,186,386.28. The trade was a 5.23 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Hitesh Ramani sold 25,000 shares of the firm’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $13.05, for a total transaction of $326,250.00. Following the transaction, the chief accounting officer now owns 269,421 shares of the company’s stock, valued at $3,515,944.05. This trade represents a 8.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 22.37% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. American Trust purchased a new stake in UiPath in the 4th quarter valued at approximately $151,000. Focus Partners Advisor Solutions LLC purchased a new position in UiPath in the 4th quarter valued at about $158,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in UiPath by 39.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,401,993 shares of the company’s stock worth $17,819,000 after acquiring an additional 397,121 shares during the last quarter. Virtus Investment Advisers Inc. acquired a new stake in shares of UiPath during the fourth quarter worth $160,000. Finally, Two Sigma Advisers LP grew its position in shares of UiPath by 29.0% in the fourth quarter. Two Sigma Advisers LP now owns 4,901,000 shares of the company’s stock valued at $62,292,000 after purchasing an additional 1,100,800 shares during the period. 62.50% of the stock is owned by hedge funds and other institutional investors.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.